| KLRS Market Cap History Table | ||||||||||||||||
Below is a table of the KLRS market cap history going back to 2/28/2025:
Also see: KLRS Shares Outstanding History and KLRS YTD Return |
KLRS Market Cap History — Kalaris Therapeutics Capitalization Over Time
As of 8/4/2026 Kalaris Therapeutics has a market cap of 102.84 million. Investors often follow the KLRS market cap history to compare the size of the company over time.
This page shows KLRS market capitalization trends over time, with 7 market cap datapoints presented, dating back to 2/28/2025.
| KLRS Market Cap History Chart | |||||||||||||||||||||
KLRS Historical Market Cap: +67.08% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||
| KLRS Stock Price Chart |
| About Kalaris Therapeutics Inc |
| AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company's proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. We show 7 historical shares outstanding datapoints in our KLRS shares outstanding history coverage, used to compute KLRS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KLRS market cap history over the course of time is important for investors interested in comparing KLRS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KLRS versus a peer is one thing; comparing KLRS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KLRS can fluctuate over the course of history. With this page we aim to empower investors researching KLRS by allowing them to research the KLRS market cap history. |
| KLRS Current Stock Quote |
Quotes delayed 20 minutes  Free KLRS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| KLRS Share Performance |
| Market Cap Peers |
| Kalaris Therapeutics (KLRS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
KMPH Market Cap History KND Market Cap History KNTE Market Cap History KOD Market Cap History KOOL Market Cap History KPRX Market Cap History KPTI Market Cap History KRBP Market Cap History KRMD Market Cap History KRON Market Cap History More Healthcare companies » |
KLRS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
